関連レポート

ゲノム編集の世界市場：2028年に至る製品サービス別、技術別予測

出版元：Transparency Market Research  出版元について

発行年：2024年4月

定価：Single User License $5795 Multi User License $8795 Corporate User License $11795

ご請求は円換算（お見積り日TTSレート）となります。

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

納品形態：PDF by Email

当調査レポートは英文 180ページになります。

商品コード：TMR254

当レポートは発行年月に関わらず、受注の都度、最新情報にアップデートしてお届けいたします。ご希望情報の追加等もご相談可能です。

レポート紹介

ゲノム・個別化医療の世界市場規模は2023年で91億ドル、2034年に330億ドル、市場の平均年成長率は12.2%に拡大すると予測されています。

当レポートでは、ゲノム・個別化医療の市場予測-2034年、各種セグメント別市場分析(パイプライン分析別、検査タイプ別、国地域別、等)、パイプライン分析、COVID-19の影響分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】
■ゲノム・個別化医療の世界市場予測2020-2034年
・市場規模(US$)

■技術別、市場-2034年
NGSプラットフォーム
RT-PCR
マイクロアレイ
遺伝子解析装置
その他
※(市場規模US$)

■検査タイプ別、市場-2034年
オンコロジー検査
感染症検査
希少疾患検査
自己免疫疾患検査
産科検査
その他
※(市場規模US$)

■エンドユーザー別、市場-2034年
学術/研究機関
診断センター
その他
※(市場規模US$)

■主要国地域別市場-2034年
北米
・米国、カナダ
欧州
・英国、ドイツ、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド、韓国
・ASEAN
・その他アジア太平洋
南米
・ブラジル、メキシコ
・その他南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照

■市場分析
市場ダイナミクス（促進要因、障壁、機会）
パイプライン分析
COVID-19の影響分析
競合状況
市場シェア分析
SWOT分析

■ゲノム・個別化医療の主要企業プロフィール動向
QIAGEN
Illumina, Inc.
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Hoffmann-La Roche AG
Lonza Group
Invitae Corp
Genetic Technologies Limited
Interleukin Genetics Inc.
Eastern Biotech and Life Sciences
DNA Genotek Inc.
uBiome, Inc.
XCode Life Sciences Private Limited
（全180頁）

Table of Contents (英文詳細目次）

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Genomics Personalized Health Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Genomics Personalized Health Market Analysis and Forecast, 2020-2034

5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Genomics Personalized Health Market Analysis and Forecast, By Technology
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, By Technology, 2020-2034
6.3.1. NGS Platform
6.3.2. RT-PCR
6.3.3. Microarray
6.3.4. Genetic Analyzer
6.3.5. Others
6.4. Market Attractiveness Analysis, By Technology

7. Global Genomics Personalized Health Market Analysis and Forecast, by Test Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Test Type, 2020-2034
7.3.1. Oncology Testing
7.3.2. Infectious Disease Testing
7.3.3. Orphan Disease Testing
7.3.4. Autoimmune Disease Testing
7.3.5. Obstetrics Testing
7.3.6. Others
7.4. Market Attractiveness Analysis, by Test Type

8. Global Genomics Personalized Health Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Academics & Research Institutes
8.3.2. Diagnostic Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user

9. Global Genomics Personalized Health Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region

10. North America Genomics Personalized Health Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, By Technology, 2020-2034
10.3.1. NGS Platform
10.3.2. RT-PCR
10.3.3. Microarray
10.3.4. Genetic Analyzer
10.3.5. Others
10.4. Market Value Forecast, by Test Type, 2020-2034
10.4.1. Oncology Testing
10.4.2. Infectious Disease Testing
10.4.3. Orphan Disease Testing
10.4.4. Autoimmune Disease Testing
10.4.5. Obstetrics Testing
10.4.6. Others
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Academics & Research Institutes
10.5.2. Diagnostic Centers
10.5.3. Others
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Technology
10.7.2. By Test Type
10.7.3. By End-user
10.7.4. By Country

11. Europe Genomics Personalized Health Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, By Technology, 2020-2034
11.3.1. NGS Platform
11.3.2. RT-PCR
11.3.3. Microarray
11.3.4. Genetic Analyzer
11.3.5. Others
11.4. Market Value Forecast, by Test Type, 2020-2034
11.4.1. Oncology Testing
11.4.2. Infectious Disease Testing
11.4.3. Orphan Disease Testing
11.4.4. Autoimmune Disease Testing
11.4.5. Obstetrics Testing
11.4.6. Others
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Academics & Research Institutes
11.5.2. Diagnostic Centers
11.5.3. Others
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Technology
11.7.2. By Test Type
11.7.3. By End-user
11.7.4. By Country/Sub-region

12. Asia Pacific Genomics Personalized Health Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, By Technology, 2020-2034
12.3.1. NGS Platform
12.3.2. RT-PCR
12.3.3. Microarray
12.3.4. Genetic Analyzer
12.3.5. Others
12.4. Market Value Forecast, by Test Type, 2020-2034
12.4.1. Oncology Testing
12.4.2. Infectious Disease Testing
12.4.3. Orphan Disease Testing
12.4.4. Autoimmune Disease Testing
12.4.5. Obstetrics Testing
12.4.6. Others
12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Technology
12.6.2. By Test Type
12.6.3. By End-user
12.6.4. By Country/Sub-region

13. Latin America Genomics Personalized Health Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, By Technology, 2020-2034
13.3.1. NGS Platform
13.3.2. RT-PCR
13.3.3. Microarray
13.3.4. Genetic Analyzer
13.3.5. Others
13.4. Market Value Forecast, by Test Type, 2020-2034
13.4.1. Oncology Testing
13.4.2. Infectious Disease Testing
13.4.3. Orphan Disease Testing
13.4.4. Autoimmune Disease Testing
13.4.5. Obstetrics Testing
13.4.6. Others
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Academics & Research Institutes
13.5.2. Diagnostic Centers
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Technology
13.7.2. By Test Type
13.7.3. By End-user
13.7.4. By Country/Sub-region

14. Middle East & Africa Genomics Personalized Health Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, By Technology, 2020-2034
14.3.1. NGS Platform
14.3.2. RT-PCR
14.3.3. Microarray
14.3.4. Genetic Analyzer
14.3.5. Others
14.4. Market Value Forecast, by Test Type, 2020-2034
14.4.1. Oncology Testing
14.4.2. Infectious Disease Testing
14.4.3. Orphan Disease Testing
14.4.4. Autoimmune Disease Testing
14.4.5. Obstetrics Testing
14.4.6. Others
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Academics & Research Institutes
14.5.2. Diagnostic Centers
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Technology
14.7.2. By Test Type
14.7.3. By End-user
14.7.4. By Country/Sub-region

15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. QIAGEN
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Illumina, Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Thermo Fisher Scientific, Inc.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Bio-Rad Laboratories, Inc.
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Hoffmann-La Roche AG
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Lonza Group
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Invitae Corp
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Genetic Technologies Limited
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Interleukin Genetics Inc.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Eastern Biotech and Life Sciences
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. DNA Genotek Inc.
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. uBiome, Inc.
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
15.3.13. XCode Life Sciences Private Limited
15.3.13.1. Company Overview
15.3.13.2. Product Portfolio
15.3.13.3. SWOT Analysis
15.3.13.4. Financial Overview
15.3.13.5. Strategic Overview

List of Tables
Table 01: Global Genomics Personalized Health Market Size (US$ Mn) Forecast, By Technology, 2020-2034

Table 02: Global Genomics Personalized Health Market Size (US$ Mn) Forecast, by Test Type, 2020-2034

Table 03: Global Genomics Personalized Health Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 04: Global Genomics Personalized Health Market Size (US$ Mn) Forecast, by Region, 2020-2034

Table 05: North America Genomics Personalized Health Market Size (US$ Mn) Forecast, by Country, 2020-2034

Table 06: North America Genomics Personalized Health Market Size (US$ Mn) Forecast, By Technology, 2020-2034

Table 07: North America Genomics Personalized Health Market Size (US$ Mn) Forecast, by Test Type, 2020-2034

Table 08: North America Genomics Personalized Health Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 09: Europe Genomics Personalized Health Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 10: Europe Genomics Personalized Health Market Size (US$ Mn) Forecast, By Technology, 2020-2034

Table 11: Europe Genomics Personalized Health Market Size (US$ Mn) Forecast, by Test Type, 2020-2034

Table 12: Europe Genomics Personalized Health Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 13: Asia Pacific Genomics Personalized Health Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 14: Asia Pacific Genomics Personalized Health Market Size (US$ Mn) Forecast, By Technology, 2020-2034

Table 15: Asia Pacific Genomics Personalized Health Market Size (US$ Mn) Forecast, by Test Type, 2020-2034

Table 16: Asia Pacific Genomics Personalized Health Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 17: Latin America Genomics Personalized Health Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 18: Latin America Genomics Personalized Health Market Size (US$ Mn) Forecast, By Technology, 2020-2034

Table 19: Latin America Genomics Personalized Health Market Size (US$ Mn) Forecast, by Test Type, 2020-2034

Table 20: Latin America Genomics Personalized Health Market Size (US$ Mn) Forecast, by End-user, 2020-2034

Table 21: Middle East & Africa Genomics Personalized Health Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034

Table 22: Middle East & Africa Genomics Personalized Health Market Size (US$ Mn) Forecast, By Technology, 2020-2034

Table 23: Middle East & Africa Genomics Personalized Health Market Size (US$ Mn) Forecast, by Test Type, 2020-2034

Table 24: Middle East & Africa Genomics Personalized Health Market Size (US$ Mn) Forecast, by End-user, 2020-2034

List of Figures

Figure 01: Global Genomics Personalized Health Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034

Figure 02: Global Genomics Personalized Health Market Revenue (US$ Mn), By Technology, 2023

Figure 03: Global Genomics Personalized Health Market Value Share, By Technology, 2023

Figure 04: Global Genomics Personalized Health Market Revenue (US$ Mn), by Test Type, 2023

Figure 05: Global Genomics Personalized Health Market Value Share, by Test Type, 2023

Figure 06: Global Genomics Personalized Health Market Revenue (US$ Mn), by End-user, 2023

Figure 07: Global Genomics Personalized Health Market Value Share, by End-user, 2023

Figure 08: Global Genomics Personalized Health Market Value Share, by Region, 2023

Figure 09: Global Genomics Personalized Health Market Value (US$ Mn) Forecast, 2020-2034

Figure 10: Global Genomics Personalized Health Market Value Share Analysis, By Technology, 2023 and 2034

Figure 11: Global Genomics Personalized Health Market Attractiveness Analysis, by Region, 2024-2034

Figure 12: Global Genomics Personalized Health Market Value Share Analysis, by Test Type, 2023 and 2034

Figure 13: Global Genomics Personalized Health Market Attractiveness Analysis, by Test Type, 2024-2034

Figure 14: Global Genomics Personalized Health Market Value Share Analysis, by End-user, 2023 and 2034

Figure 15: Global Genomics Personalized Health Market Attractiveness Analysis, by End-user, 2024-2034

Figure 16: Global Genomics Personalized Health Market Value Share Analysis, by Region, 2023 and 2034

Figure 17: Global Genomics Personalized Health Market Attractiveness Analysis, by Region, 2024-2034

Figure 18: North America Genomics Personalized Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 19: North America Genomics Personalized Health Market Attractiveness Analysis, by Country, 2024-2034

Figure 20: North America Genomics Personalized Health Market Value Share Analysis, by Country, 2023 and 2034

Figure 21: North America Genomics Personalized Health Market Value Share Analysis, By Technology, 2023 and 2034

Figure 22: North America Genomics Personalized Health Market Value Share Analysis, by Test Type, 2023 and 2034

Figure 23: North America Genomics Personalized Health Market Value Share Analysis, by End-user, 2023 and 2034

Figure 24: North America Genomics Personalized Health Market Attractiveness Analysis, by Region, 2024-2034

Figure 25: North America Genomics Personalized Health Market Attractiveness Analysis, by Test Type, 2024-2034

Figure 26: North America Genomics Personalized Health Market Attractiveness Analysis, by End-user, 2024-2034

Figure 27: Europe Genomics Personalized Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 28: Europe Genomics Personalized Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 29: Europe Genomics Personalized Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 30: Europe Genomics Personalized Health Market Value Share Analysis, By Technology, 2023 and 2034

Figure 31: Europe Genomics Personalized Health Market Value Share Analysis, by Test Type, 2023 and 2034

Figure 32: Europe Genomics Personalized Health Market Value Share Analysis, by End-user, 2023 and 2034

Figure 33: Europe Genomics Personalized Health Market Attractiveness Analysis, by Region, 2024-2034

Figure 34: Europe Genomics Personalized Health Market Attractiveness Analysis, by Test Type, 2024-2034

Figure 35: Europe Genomics Personalized Health Market Attractiveness Analysis, by End-user, 2024-2034

Figure 36: Asia Pacific Genomics Personalized Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 37: Asia Pacific Genomics Personalized Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 38: Asia Pacific Genomics Personalized Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 39: Asia Pacific Genomics Personalized Health Market Value Share Analysis, By Technology, 2023 and 2034

Figure 40: Asia Pacific Genomics Personalized Health Market Value Share Analysis, by Test Type, 2023 and 2034

Figure 41: Asia Pacific Genomics Personalized Health Market Value Share Analysis, by End-user, 2023 and 2034

Figure 42: Asia Pacific Genomics Personalized Health Market Attractiveness Analysis, by Region, 2024-2034

Figure 43: Asia Pacific Genomics Personalized Health Market Attractiveness Analysis, by Test Type, 2024-2034

Figure 44: Asia Pacific Genomics Personalized Health Market Attractiveness Analysis, by End-user, 2024-2034

Figure 45: Latin America Genomics Personalized Health Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 46: Latin America Genomics Personalized Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 47: Latin America Genomics Personalized Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 48: Latin America Genomics Personalized Health Market Value Share Analysis, By Technology, 2023 and 2034

Figure 49: Latin America Genomics Personalized Health Market Value Share Analysis, by Test Type, 2023 and 2034

Figure 50: Latin America Genomics Personalized Health Market Value Share Analysis, by End-user, 2023 and 2034

Figure 51: Latin America Genomics Personalized Health Market Attractiveness Analysis, by Region, 2024-2034

Figure 52: Latin America Genomics Personalized Health Market Attractiveness Analysis, by Test Type, 2024-2034

Figure 53: Latin America Genomics Personalized Health Market Attractiveness Analysis, by End-user, 2024-2034

Figure 54: Middle East & Africa Genomics Personalized Health Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034

Figure 55: Middle East & Africa Genomics Personalized Health Market Attractiveness Analysis, by Country/Sub-region, 2024-2034

Figure 56: Middle East & Africa Genomics Personalized Health Market Value Share Analysis, by Country/Sub-region, 2023 and 2034

Figure 57: Middle East & Africa Genomics Personalized Health Market Value Share Analysis, By Technology, 2023 and 2034

Figure 58: Middle East & Africa Genomics Personalized Health Market Value Share Analysis, by Test Type, 2023 and 2034

Figure 59: Middle East & Africa Genomics Personalized Health Market Value Share Analysis, by End-user, 2023 and 2034

Figure 60: Middle East & Africa Genomics Personalized Health Market Attractiveness Analysis, by Region, 2024-2034

Figure 61: Middle East & Africa Genomics Personalized Health Market Attractiveness Analysis, by Test Type, 2024-2034

Figure 62: Middle East & Africa Genomics Personalized Health Market Attractiveness Analysis, by End-user, 2024-2034

△ 一番上に戻る